Reuters logo
BRIEF-Navidea enters exclusive license, distribution agreement for India with Sayre Therapeutics
2017年6月20日 / 下午2点55分 / 3 个月前

BRIEF-Navidea enters exclusive license, distribution agreement for India with Sayre Therapeutics

June 20 (Reuters) - Navidea Biopharmaceuticals Inc:

* Navidea enters exclusive license and distribution agreement for India with Sayre Therapeutics

* Agreement with Sayre Therapeutics for development and commercialization of tc 99m tilmanocept in india

* Under terms, Co eligible to receive milestone payments, royalties associated with sale of tc 99m Tilmanocept in India

* Under terms of agreement, Navidea received an upfront payment Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below